KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

FAMOCID 40 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

40 MG

 

GENERIC NAME:

FAMOTIDINE

 

MANUFACTURER:

SPIMACO

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Adenoma, multiple endocrine

Esophagitis, erosive

Gastroesophageal Reflux Disease

Ulcer, duodenal

Ulcer, gastric

Zollinger- Ellison syndrome

 

SIDE EFFECTS:

agitation

alopecia

confusion

constipation

delirium

depression

diarrhea

dizziness

hallucinations

headache

insomnia

paranoia

pruritus

urticaria

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

breast-feeding

children

elderly

gastric cancer

GI bleeding

2-blocker*hypersensitivity#243"H2-blocker hypersensitivity

hepatic disease

infection

phenylketonuria

pregnancy

renal disease

renal failure

renal impairment

 

ADULT DOSE:

Duodenal ulcer-Treatment: Oral, 40 mg once a day at bedtime or 20 mg two times a day. Prophylaxis of recurrent duodenal ulcer: Oral, 20 mg at bedtime. Gastric ulcer, benign, active-Treatment: Oral, 40 mg once a day at bedtime. Heartburn, acid indigestion, and sour stomach-Treatment: Oral, 10 mg at onset of symptoms; dose may be repeated once in twenty-four hours Prophylaxis: Oral, 10 mg up to one hour before consuming food or beverages expected to cause symptoms Gastric hypersecretory conditions (e.g., Zollinger-Ellison syndrome, systemic mastocytosis, multiple endocrine adenomas)-Oral, 20 mg every six hours, the dosage being adjusted as needed and therapy continued for as long as clinically indicated. Doses up to 160 mg every six hours have been administered to some patients with severe Zollinger-Ellison syndrome. Gastroesophageal reflux-Oral, 20 mg two times a day for up to six weeks. Note: The recommended oral dose for esophagitis due to gastroesophageal reflux disease is 20 to 40 mg two times a day for up to twelve weeks. [Prophylaxis of aspiration pneumonitis]-Oral, 40 mg given either the night before or the morning of surgery. Note: For patients with severely impaired renal function (creatinine clearance less than 10 mL per minute)-Oral, 20 mg at bedtime. Depending on patient's response, the dosing interval may have to be increased to thirty-six to forty-eight hours

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Duodenal ulcer or Gastric ulcer-Oral, initially 0.5 mg per kg of body weight a day, at bedtime or in two divided doses. Gastroesophageal reflux disease-For children weighing more than 10 kg: Oral, 1 to 2 mg per kg of body weight a day, in two divided doses. For children weighing less than 10 kg: Oral, 1 to 2 mg per kg per day, in three divided doses. Note: In certain circumstances, doses may be titrated based on gastric pH. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

Duodenal ulcer-Treatment: Oral, 40 mg once a day at bedtime or 20 mg two times a day. Prophylaxis of recurrent duodenal ulcer: Oral, 20 mg at bedtime. Gastric ulcer, benign, active-Treatment: Oral, 40 mg once a day at bedtime. Heartburn, acid indigestion, and sour stomach-Treatment: Oral, 10 mg at onset of symptoms; dose may be repeated once in twenty-four hours Prophylaxis: Oral, 10 mg up to one hour before consuming food or beverages expected to cause symptoms Gastric hypersecretory conditions (e.g., Zollinger-Ellison syndrome, systemic mastocytosis, multiple endocrine adenomas)-Oral, 20 mg every six hours, the dosage being adjusted as needed and therapy continued for as long as clinically indicated. Doses up to 160 mg every six hours have been administered to some patients with severe Zollinger-Ellison syndrome. Gastroesophageal reflux-Oral, 20 mg two times a day for up to six weeks. Note: The recommended oral dose for esophagitis due to gastroesophageal reflux disease is 20 to 40 mg two times a day for up to twelve weeks. [Prophylaxis of aspiration pneumonitis]-Oral, 40 mg given either the night before or the morning of surgery. Note: For patients with severely impaired renal function (creatinine clearance less than 10 mL per minute)-Oral, 20 mg at bedtime. Depending on patient's response, the dosing interval may have to be increased to thirty-six to forty-eight hours

 

 

PREVIOUS

  

NEXT